Pembrolizumab Plus Lenvatinib Linked to Reversible Confusion and Akathisia
A 2026 case report describes a 69-year-old woman with anxiety and depression who became confused, slowed and severely restless on pembrolizumab plus lenvatinib and sedating psychiatric drugs…
Read article